Cardiovascular safety of mirabegron add‐on therapy to tamsulosin for the treatment of overactive bladder in men with lower urinary tract symptoms: A post hoc analysis from the MATCH study

OBJECTIVES: To investigate the cardiovascular safety of mirabegron add‐on treatment to tamsulosin in male patients with residual overactive bladder symptoms. METHODS: This was a post hoc analysis of MATCH, the first double‐blind, placebo‐controlled study comparing mirabegron and placebo as add‐on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Katoh, Takao, Kakizaki, Hidehiro, Lee, Kyu‐Sung, Ishida, Kota, Katou, Daisuke, Yamamoto, Osamu, Jong, Jar Jar, Sumarsono, Budiwan, Uno, Satoshi, Yamaguchi, Osamu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Asia Pty Ltd 2020
Materias:
Original Articles–Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821249/
https://www.ncbi.nlm.nih.gov/pubmed/32975024
http://dx.doi.org/10.1111/luts.12339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821249/
https://www.ncbi.nlm.nih.gov/pubmed/32975024
http://dx.doi.org/10.1111/luts.12339

Ejemplares similares